Clinical Professor of Medicine, University of Illinois College of Medicine
Family Medicine
Dr. Peter Toth, MD
|
|
Give Review
Dr. Peter Toth is an expert in the field of Family Medicine. He attended Wayne State University School of Medicine. Wayne State University School of Medicine is ranked 63 in research and 85 in primary care medicine He received awards:"Regional Top Doctor", "CMS Meaningful Use Stage 1 Certification" and "Fellow (FACC)". Peter Toth is a published doctor. He published 31 publications, including: 'Pitavastatin 4 mg Provides Significantly Greater Reduction in Remnant Lipoprotein Cholesterol Compared With Pravastatin 40 mg: Results from the Short-Term Phase IV PRE...' He accepts Medicare payments and is registered with Medicare.gov.
Publications
- Pitavastatin 4 mg Provides Significantly Greater Reduction in Remnant Lipoprotein Cholesterol Compared With Pravastatin 40 mg: Results from the Short-Term Phase IV PRE...
- Treatment of Dyslipidemia in Elderly Patients With Coronary Heart Disease: There Are Miles to Go Before We Sleep.
- Relationship of the triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio to the remainder of the lipid profile: The Very Large Database of Lipids-4 (V...
- Integrin α6β1 Expressed in ESCs Instructs the Differentiation to Endothelial Cells.
- Recommendations for the management of patients with familial hypercholesterolemia.
- Bioenergetic shifts during transitions between stem cell states (2013 Grover Conference series).
- HDL cholesterol subclasses, myocardial infarction, and mortality in secondary prevention: the lipoprotein investigators collaborative.
- Direct oral anticoagulants as alternative treatment options for the effective long-term treatment of patients with pulmonary embolism in primary care: a review.
- High-density lipoprotein subfractions: current views and clinical practice applications.
- HDL hypothesis: where do we stand now?
- An update on the benefits and risks of rosuvastatin therapy.
- The Therapeutic Role of Niacin in Dyslipidemia Management.
- Cardiac glutaminolysis: a maladaptive cancer metabolism pathway in the right ventricle in pulmonary hypertension.
- SLIT3-ROBO4 activation promotes vascular network formation in human engineered tissue and angiogenesis in vivo.
- Insulin Resistance, Small LDL Particles, and Risk for Atherosclerotic Disease.
- FOXO1-mediated upregulation of pyruvate dehydrogenase kinase-4 (PDK4) decreases glucose oxidation and impairs right ventricular function in pulmonary hypertension: the...
- PGC1?-Mediated Mitofusin-2 Deficiency in Female Rats and Humans With Pulmonary Arterial Hypertension.
- Is the future of statins aligned with new novel lipid modulation therapies?
- Role of Dynamin Related Protein 1 (Drp1)-Mediated Mitochondrial Fission in Oxygen-Sensing and Constriction of the Ductus Arteriosus.
- GRK2-mediated inhibition of adrenergic and dopaminergic signaling in right ventricular hypertrophy: therapeutic implications in pulmonary hypertension.
- The potential role of prasugrel in secondary prevention of ischemic events in patients with acute coronary syndromes.
- Effect of alirocumab on specific lipoprotein non-high-density lipoprotein cholesterol and subfractions as measured by the vertical auto profile method: analysis of 3 r...
- Use of microsomal triglyceride transfer protein inhibitors in patients with homozygous familial hypercholesterolemia: translating clinical trial experience into clinic...
- A clinician's guide to statin drug-drug interactions.
- Dyslipidemia in women: etiology and management.
- Flk1+ and VE-Cadherin+ Endothelial Cells Derived from iPSCs Recapitulates Vascular Development during Differentiation and Display Similar Angiogenic Potential as ESC-D...
- Mitochondrial respiration regulates adipogenic differentiation of human mesenchymal stem cells.
- High-density lipoproteins: A consensus statement from the National Lipid Association.
- Obesity, adiposity, and dyslipidemia: A consensus statement from the National Lipid Association.
- Emerging LDL therapies: Mipomersen-antisense oligonucleotide therapy in the management of hypercholesterolemia.
Schools
Wayne State University School Of Medicine
University Iowa Hosps and Clins
Doctors Specialties
- Family Medicine
Accepted Insurances
- Choice Plus POS II
- American Enterprise Group
- American Republic
- Assurant Health
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- Coventry Health Care
- Coventry Health Care of Illinois PPO
- Health and Life PPO
- Platinum PPO
- Coventry Health Care of Missouri PPO
- First Health (Coventry Health Care) PPO
- Golden Rule
- Health Alliance PPO
- Choice Care PPO
- Preferred PPO
- MedHealthInsurance
- Medicare MCR
- Medico
- MultiPlan PPO
- PHCS Network PPO
- Pekin Insurance
- Thrivent Financial
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Awards
- Regional Top Doctor
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACC)
Education
-
University of Iowa Hospitals and Clinics -
Wayne State University School of Medicine
Helpful Reviews
Similar Doctors
|
|
Dr. Phong D. Dang, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sharath Reniguntala, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eric Kuhns, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paul Steinke, DO |
|
|
Dr. Angel Blazquez, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Pedro M. Peralta Jr., MD |
|
|
Dr. Michael D. Galle, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Theodore L. Moss, DMD |
|
|
Dr. Afrem Malki, MD
This Doctor is OpenDoctor Recommended.
|